Barbara MD - Forte Biosciences Chief Director

FBRX Stock  USD 23.46  1.75  8.06%   

Director

Barbara MD is Chief Director of Forte Biosciences
Age 77
Address 3060 Pegasus Park Drive, Dallas, TX, United States, 75247
Phone310 618 6994
Webhttps://www.fortebiorx.com

Forte Biosciences Management Efficiency

The company has return on total asset (ROA) of (0.8125) % which means that it has lost $0.8125 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7091) %, meaning that it created substantial loss on money invested by shareholders. Forte Biosciences' management efficiency ratios could be used to measure how well Forte Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.85 in 2024. Return On Capital Employed is likely to rise to -0.87 in 2024. At this time, Forte Biosciences' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 831.9 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 620.4 K in 2024.
Forte Biosciences currently holds 3.67 M in liabilities. Forte Biosciences has a current ratio of 25.16, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Forte Biosciences' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 1 records

DIRECTOR Age

TsungShann EMBAABVC Biopharma
70
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. Forte Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 6 people. Forte Biosciences (FBRX) is traded on NASDAQ Exchange in USA. It is located in 3060 Pegasus Park Drive, Dallas, TX, United States, 75247 and employs 11 people. Forte Biosciences is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Forte Biosciences Leadership Team

Elected by the shareholders, the Forte Biosciences' board of directors comprises two types of representatives: Forte Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Forte. The board's role is to monitor Forte Biosciences' management team and ensure that shareholders' interests are well served. Forte Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Forte Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
Antony CPA, Chief Officer
Steven Ruhl, Chief Officer
Paul Wagner, President CEO
Hubert MD, President Officer
Christopher Roenfeldt, Chief Officer
Barbara MD, Chief Director

Forte Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Forte Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.